Genome-Wide Placental Gene Methylations in Gestational Diabetes Mellitus, Fetal Growth and Metabolic Health Biomarkers in Cord Blood.
Genome-Wide Placental Gene Methylations in Gestational Diabetes Mellitus, Fetal Growth and Metabolic Health Biomarkers in Cord Blood.
复制标题
妊娠期糖尿病、胎儿生长和代谢健康中脐带血生物标志物的全基因组胎盘基因甲基化
DOI:
10.3389/fendo.2022.875180
复制
发表时间:
2022
影响因子:
5.2
通讯作者:
中科院分区:
文献类型:
--
作者:
Gestational diabetes mellitus (GDM) “program” an elevated risk of metabolic syndrome in the offspring. Epigenetic alterations are a suspected mechanism. GDM has been associated with placental DNA methylation changes in some epigenome-wide association studies. It remains unclear which genes or pathways are affected, and whether any placental differential gene methylations are correlated to fetal growth or circulating metabolic health biomarkers. In an epigenome-wide association study using the Infinium MethylationEPIC Beadchip, we sought to identify genome-wide placental differentially methylated genes and enriched pathways in GDM, and to assess the correlations with fetal growth and metabolic health biomarkers in cord blood. The study samples were 30 pairs of term placentas in GDM vs. euglycemic pregnancies (controls) matched by infant sex and gestational age at delivery in the Shanghai Birth Cohort. Cord blood metabolic health biomarkers included insulin, C-peptide, proinsulin, IGF-I, IGF-II, leptin and adiponectin. Adjusting for maternal age, pre-pregnancy BMI, parity, mode of delivery and placental cell type heterogeneity, 256 differentially methylated positions (DMPs,130 hypermethylated and 126 hypomethylated) were detected between GDM and control groups accounting for multiple tests with false discovery rate <0.05 and beta-value difference >0.05. WSCD2 was identified as a differentially methylated gene in both site- and region-level analyses. We validated 7 hypermethylated (CYP1A2, GFRA1, HDAC4, LIMS2, NAV3, PAX6, UPK1B) and 10 hypomethylated (DPP10, CPLX1, CSMD2, GPR133, NRXN1, PCSK9, PENK, PRDM16, PTPRN2, TNXB) genes reported in previous epigenome-wide association studies. We did not find any enriched pathway accounting for multiple tests. DMPs in 11 genes (CYP2D7P1, PCDHB15, ERG, SIRPB1, DKK2, RAPGEF5, CACNA2D4, PCSK9, TSNARE1, CADM2, KCNAB2) were correlated with birth weight (z score) accounting for multiple tests. There were no significant correlations between placental gene methylations and cord blood biomarkers. In conclusions, GDM was associated with DNA methylation changes in a number of placental genes, but these placental gene methylations were uncorrelated to the observed metabolic health biomarkers (fetal growth factors, leptin and adiponectin) in cord blood. We validated 17 differentially methylated placental genes in GDM, and identified 11 differentially methylated genes relevant to fetal growth.
登录
查看更多内容
影响因子:
4.8
作者:
Han, P;Werber, J;Michaeli, T
通讯作者:
Michaeli, T
影响因子:
2.1
作者:
Gao C;Hsu FC;Dimitrov LM;Okut H;Chen YI;Taylor KD;Rotter JI;Langefeld CD;Bowden DW;Palmer ND
通讯作者:
Palmer ND
影响因子:
3.6
作者:
Itoh, Nobuyuki
通讯作者:
Itoh, Nobuyuki
影响因子:
5.6
作者:
Gagne-Ouellet, Valerie;Breton, Edith;Bouchard, Luigi
通讯作者:
Bouchard, Luigi
影响因子:
3.8
作者:
Logue MW;Smith AK;Wolf EJ;Maniates H;Stone A;Schichman SA;McGlinchey RE;Milberg W;Miller MW
通讯作者:
Miller MW